Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Gender issues
Sessions
Wednesday, 23 November
10:50
Drug policy: socio-political influence, cultural diversity
10:50
to
12:20
Insights zone 1 (I1)
InterGLAM cinema
Foetal Alcohol Syndrome: piloting best practices towards FAS/FASD prevention. Results from the FAR SEAS European project
10:50
to
12:20
Central square 1 (C1)
Structured session
16:50
Addiction and comorbidity over the lifespan: mechanisms and interventions
16:50
to
18:20
Central square 2 (C2)
Structured session
Focusing on gender issues
16:50
to
18:20
Central square 3 (C3)
Oral presentation session
Treatment options for drug users in prisons in Central Asia and Germany
16:50
to
18:20
Networking zone 1 (N1)
Structured session
Thursday, 24 November
09:00
Contemporary Issues
09:00
to
10:30
Central square 2 (C2)
Oral presentation session
10:50
Alcohol and AUD during the life-cycle
10:50
to
12:20
Networking zone 3 (N3)
Short communication session
Understanding women's drug use, responses and recovery
10:50
to
12:20
Networking zone 4 (N4)
Short communication session
15:00
Drug deaths: A social, structural and systems analysis
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
Friday, 25 November
10:50
Gender differences and gender identities in drug use, addiction and interventions: why gender matters
10:50
to
12:20
Networking zone 3 (N3)
Structured session
Substance use and sexual behaviours
10:50
to
12:20
Knowledge market 4 (K4)
Oral presentation session
13:20
Substance use consequences and concerns
13:20
to
14:50
Networking zone 1 (N1)
e-poster guided tour
The experience of persons in homeless situation with alcohol related problems regarding a pharmacological harm reduction initiative
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Understanding drug use, risk and harm
13:20
to
14:50
Networking zone 2 (N2)
e-poster guided tour
Presentations
Wednesday, 23 November
10:50
Oral presentation
1. Guidelines to reduce alcohol consumption in women of child-bearing age
10:50
to
12:20
Central square 1 (C1)
Carla Bruguera
Oral presentation
2. Training of trainers package on FAS/FASD prevention
10:50
to
12:20
Central square 1 (C1)
Lidia Segura
Oral presentation
3. Piloting an evidence-based good practice intervention for reducing the risk of FASD
10:50
to
12:20
Central square 1 (C1)
Katarzyna Okulicz-Kozaryn
Discussion
Transferability issues, dissemination of results and implementation in other countries
10:50
to
12:20
Central square 1 (C1)
Oral presentation
1. Gender-sensitive drug policy
10:50
to
12:20
Insights zone 1 (I1)
Gabriele Fischer
Oral presentation
2. Youth-centered drug policy
10:50
to
12:20
Insights zone 1 (I1)
Danya Fast
Oral presentation
3. Perspectives of people who use drugs on drug policy
10:50
to
12:20
Insights zone 1 (I1)
Mat Southwell
Introduction
Drug policy: socio-political influence, cultural diversity
10:50
to
12:20
Insights zone 1 (I1)
Abhishek Ghosh
16:50
Oral presentation
1. First findings of an RCT on treatment of PTSD in addiction: simultaneous or sequential treatment with EMDR, Prolonged Exposure, Imaginary Rescripting
16:50
to
18:20
Central square 2 (C2)
Nathalie Faber
Oral presentation
2. Older adults and alcohol use: negative affect, resilience, and alcohol use as interacting factors
16:50
to
18:20
Central square 2 (C2)
Yannick van Gils
Oral presentation
3. Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: findings of a pragmatic randomized controlled trial
16:50
to
18:20
Central square 2 (C2)
Maria J.E. Schouten
Oral presentation
4. Illegal substance use during pregnancy: what do we know about risks and detoxification?
16:50
to
18:20
Central square 2 (C2)
Cleo L. Crunelle
Oral presentation
An international rapid review of the needs and an indirect estimate of the national prevalence of women who use substances and endure domestic violence.
16:50
to
18:20
Central square 3 (C3)
Catherine Comiskey
Oral presentation
What are the attitudes of pregnant women and mothers concerning maternal alcohol use, and what factors are associated with increased maternal drinking?
16:50
to
18:20
Central square 3 (C3)
Abi Rose
Oral presentation
Identifying the needs of mothers in substance use treatment services using electronic health records
16:50
to
18:20
Central square 3 (C3)
Martha Canfield
Oral presentation
Metzineres. Environments of Shelter for Womxn who use drugs surviving violence
16:50
to
18:20
Central square 3 (C3)
Aura Roig Forteza
Oral presentation
Prevalence of Tobacco Smoking in Austria. Differences between Women and Men
16:50
to
18:20
Central square 3 (C3)
Irene Schmutterer
Oral presentation
1. The role of social work in agency processes - empirical study using the example of people who use illicit substances with a history of imprisonment
16:50
to
18:20
Networking zone 1 (N1)
Daniela Jamin
Oral presentation
2. Social work with drug users in a probation system of Kyrgyzstan
16:50
to
18:20
Networking zone 1 (N1)
Estebes uulu Tynchtyk
Oral presentation
3. Health and social welfare in prisons in the Republic of Kazakhstan – women with HIV and the role of the social worker
16:50
to
18:20
Networking zone 1 (N1)
Dalida Mukasheva
Thursday, 24 November
09:00
Oral presentation
Stakeholders’ perceptions about their position and the dynamics between the stakeholders within Swedish drug policy field
09:00
to
10:30
Central square 2 (C2)
Tuulia Lerkkanen
Oral presentation
Switching from a criminalisation to a public health approach to injecting drug use in Eastern Europe and Central Asia: a modelling analysis of the costs and impact on HIV transmission
09:00
to
10:30
Central square 2 (C2)
Zoe Ward
Oral presentation
Addressing intimate partner abuse (IPA) perpetrated by heterosexual men in substance use treatment: the ADVANCE programme
09:00
to
10:30
Central square 2 (C2)
Gail Gilchrist
Oral presentation
ROSE: A peer-led intervention to support peer workers in overdose response settings in British Columbia
09:00
to
10:30
Central square 2 (C2)
Fred Cameron
10:50
Short communication
Alcohol and pregnancy – knowledge, perspetives and practice of Portuguese health professionals working with pregnant women
10:50
to
12:20
Networking zone 3 (N3)
Maria Xavier
Short communication
Youth drinking in decline
10:50
to
12:20
Networking zone 3 (N3)
Johanna Loy
Short communication
Fresh Onward'. A study on group-based treatment programs for elderly with problematic alcohol use
10:50
to
12:20
Networking zone 3 (N3)
Rob Bovens
Short communication
Perceptions of family functioning in families with alcoholics in treatment
10:50
to
12:20
Networking zone 3 (N3)
Irma Kovco Vukadin
Short communication
The validity of a Screening Instrument for Intimate Partner Violence in Men with Substance Use Disorders seen in addiction specialist services.
10:50
to
12:20
Networking zone 3 (N3)
Ariadna Sanchez Codern
Short communication
The importance of social support in the treatment of alcoholism - a study from Croatia
10:50
to
12:20
Networking zone 3 (N3)
Dalibor Dolezal
Short communication
Gender differences in cannabis use disorder symptoms: A network analysis
10:50
to
12:20
Networking zone 4 (N4)
Emese Kroon
Short communication
Photovoicing interconnected sources of recovery capital of women with a drug use history
10:50
to
12:20
Networking zone 4 (N4)
Jessica De Maeyer
Short communication
Complex social and health care needs of women who seek addiction treatment: listening to their voices to guide long-term integrated services that take into account gender
10:50
to
12:20
Networking zone 4 (N4)
Karine Bertrand
Short communication
Mutual help groups for women who use drugs, as a community-led gender sensitive harm reduction response
10:50
to
12:20
Networking zone 4 (N4)
LÃgia Parodi
Short communication
Exploring intersections between gender and drug use in East and Southern Africa
10:50
to
12:20
Networking zone 4 (N4)
Charity Monareng
Short communication
Mutual support groups among women who use drugs in a community context as a comprehensive and affordable strategy to reduce inequalities
10:50
to
12:20
Networking zone 4 (N4)
Joana Canedo
15:00
Oral presentation
4. The role of Primary Care in the prevention of drug-related deaths: service provider perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Betsy Thom
Oral presentation
5. Drug Policy and The Rise and Decline of Racial Stratification of Prescribing and Overdose Mortality
15:00
to
16:30
Knowledge market 1 (K1)
Brian Kelly
Oral presentation
1. Drug-related deaths among young people: a social, structural and systems autopsy
15:00
to
16:30
Knowledge market 1 (K1)
Aileen O'Gorman
Oral presentation
2. Drug-related deaths in prisons in England and Wales, 2015-2020: an examination of key trends and issues for policy and practice
15:00
to
16:30
Knowledge market 1 (K1)
Karen Duke
Oral presentation
3. The role of Primary Care in the prevention of drug-related deaths: Patient and family member perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Katie Colliver
Discussion
What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?
15:00
to
16:30
Knowledge market 1 (K1)
Anne Whittaker
Friday, 25 November
10:50
Oral presentation
6. Implementing a gender dimension in drug policy and practice: findings from the Pompidou Group handbook for practitioners and decision makers
10:50
to
12:20
Networking zone 3 (N3)
Sarah Morton
Oral presentation
5. Drug use among non-binary persons in Europe: findings from a web survey
10:50
to
12:20
Networking zone 3 (N3)
Cristiana Vale Pires
Oral presentation
1. What is gender and why it is necessary to incorporate a gender perspective in the drug field? Evolution of key theoretical concepts in the area of gender and trends influencing the drug field
10:50
to
12:20
Networking zone 3 (N3)
Analia Torres
Oral presentation
2. Gender differences in drug use from a social perspective
10:50
to
12:20
Networking zone 3 (N3)
Nuria Romo
Oral presentation
3. Sex differences in drug use and drug addiction from a neuroscience perspective
10:50
to
12:20
Networking zone 3 (N3)
Anne Marije Kaag
Oral presentation
4. Using an intersectional risk environment approach to understand health and drug outcomes: Looking across social locations
10:50
to
12:20
Networking zone 3 (N3)
Alexandra B. Collins
Oral presentation
PnP/CHEMSEX a means of surviving post-migration
10:50
to
12:20
Knowledge market 4 (K4)
Alexandre Brulotte
Oral presentation
Don’t cure, but care': affirmative intervention amongst men of sexual and gender diversity in the context of chemsex
10:50
to
12:20
Knowledge market 4 (K4)
Yannick Gaudette
Oral presentation
Identity matters in understanding gay and bisexual men's injecting drug use: a grounded theory study
10:50
to
12:20
Knowledge market 4 (K4)
Sophia Elvira Schroeder
Oral presentation
Interpersonal needs of gay, bisexual, and other msm who practice sexualized substance use: a critical component in treating substance use disorders among sexual minorities
10:50
to
12:20
Knowledge market 4 (K4)
Joseph De Piano
Oral presentation
The needs of professionals working on sexualized substance use and its implications for health and social services
10:50
to
12:20
Knowledge market 4 (K4)
Jorge Flores-Aranda
Discussion
Recent developments in the gender field: the EIGE’s perspective
10:50
to
12:20
Networking zone 3 (N3)
13:20
e-poster
Gender differences in HIV prevalence and all-cause mortality among people who inject drugs (PWID) in Estonia.
13:20
to
14:50
Networking zone 1 (N1)
Maris Salekesin
e-poster
Changes in substance use during the COVID-19 pandemic: Longitudinal analysis of risk behavior and mental health of MSM using HIV pre-exposure prophylaxis
13:20
to
14:50
Networking zone 2 (N2)
Babette Lea Winter
e-poster
Interaction between Alcohol Use Disorder, APOE4 and Cognitive Decline in patients undergoing an alcohol detoxification program
13:20
to
14:50
Networking zone 1 (N1)
Laura Orio
e-poster
Non-prescribed buprenorphine and reduction in illicit opioids use among individuals with opioid use disorder: a longitudinal study
13:20
to
14:50
Networking zone 2 (N2)
Raminta Daniulaityte
e-poster
Functional Connectivity in a Triple-Network Saliency Model is Associated with Real-Life Self-Control
13:20
to
14:50
Networking zone 1 (N1)
Klaus-Martin Krönke
e-poster
Sexualized substance use, consumption motives and risk factors for relapse of addiction patients. Results of a cross-sectional study in addiction treatment facilities in Germany.
13:20
to
14:50
Networking zone 2 (N2)
Daniel Deimel
e-poster
Lifestyle risk factors and racial and ethnic inequality in mortality: Decomposing differential exposure and vulnerability in the United States
13:20
to
14:50
Networking zone 1 (N1)
Klajdi Puka
e-poster
How hair keeps track: Associations between hair concentrations of psychoactive substances and steroid hormones in a large cohort sample of young adults in Switzerland
13:20
to
14:50
Networking zone 2 (N2)
Lydia Johnson-Ferguson
e-poster
Demographic and socio-structural factors associated with non-fatal overdose among patients enrolled in the OPTIMA trial
13:20
to
14:50
Networking zone 1 (N1)
Hannah Crepeault
e-poster
Changes in sexualised and non-sexualised drug use among LGBT+ people during the COVID-19 pandemic: A systematic review
13:20
to
14:50
Networking zone 2 (N2)
Dean Connolly
e-poster
Acceptance-based, intersectional stigma coping intervention for people with HIV who inject drugs – an RCT in St. Petersburg, Russia
13:20
to
14:50
Networking zone 1 (N1)
Karsten Lunze
e-poster
Novel Psychoactive Substances (NPS) related health responses implemented in Europe through the lens of an intersectional risk environment approach
13:20
to
14:50
Networking zone 1 (N1)
Jessica Neicun
e-poster
Four-year long wastewater-based monitoring of illicit drug consumption pilot project in Switzerland
13:20
to
14:50
Networking zone 2 (N2)
Livia Andrani
e-poster
How are profiles of substance use linked to social function in the following seven years?
13:20
to
14:50
Networking zone 2 (N2)
Sidsel Karsberg
e-poster
A systematic review of self-report and behavioural measures of the Addiction Neuroclinical Assessment constructs of incentive salience and negative emotionality, in adults who use psychoactive drugs.
13:20
to
14:50
Networking zone 2 (N2)
Maria Bravo Aguilera
e-poster
Alcohol Consumption during a Pandemic Lockdown Period and Change in Alcohol Consumption Related to Worries and Pandemic Measures
13:20
to
14:50
Networking zone 1 (N1)
Silvia Eiken Alpers
e-poster
Abuse of prescription psychoactive medicines
13:20
to
14:50
Networking zone 2 (N2)
Darja Lavtar
e-poster
Suicide and self-harm among people prescribed opioid agonist treatment in New South Wales: a retrospective data linkage study
13:20
to
14:50
Networking zone 2 (N2)
Samantha Colledge-Frisby
Oral presentation
2. The experience of persons in homeless situation with alcohol related problems regarding a pharmacological harm reduction initiative
13:20
to
14:50
Knowledge market 4 (K4)
Raquel Medinas
Oral presentation
4. The role of those without a role - The perspective of non-clinical professionals in emergencyshelters on how to manage alcohol use disorder - police, security agents and cleaning staff
13:20
to
14:50
Knowledge market 4 (K4)
Ricardo Fuertes
Oral presentation
3. Amidst the most vulnerable voices: women and migrants in homeless situation with Alcohol UseDisorders (AUD)
13:20
to
14:50
Knowledge market 4 (K4)
MÃ rio Santos
Oral presentation
5. All we can do - Emergency Shelter' staff positioning regarding alcohol related problems in thecontext of a new harm reduction intervention
13:20
to
14:50
Knowledge market 4 (K4)
Joana Tavares
Oral presentation
1. Individuals with lived experience of homelessness and alcohol use disorders - insights from the PLACE study
13:20
to
14:50
Knowledge market 4 (K4)
Ana Neto